While BCOR alterations are commonly observed in endometrial stromal sarcoma (ESS), they have also been identified in a subset of ossifying fibromyxoid tumors (Antonescu et al., 2014 Feb). This evidence concerns the gene BCOR and endometrioid stromal sarcoma.